February 14, 2020 / 11:19 AM / in 11 days

BRIEF-Cytodyn Announced Continued Positive Data For Its Mtnbc And Mbc Patients

Feb 14 (Reuters) - Cytodyn Inc:

* CYTODYN REPORTS CONTINUED POSITIVE CLINICAL DATA ON ITS PHASE 1B/2 MTNBC AND EXPANDED ACCESS STUDIES FOR MBC AHEAD OF BREAKTHROUGH THERAPY DESIGNATION DECISION FROM THE FDA

* CYTODYN INC - ANNOUNCED CONTINUED POSITIVE DATA FOR ITS MTNBC AND MBC PATIENTS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below